News & Updates

Show Multimedia Only

SGLT-2 inhibitors show no risk increase in UTI among veterans

28 Jul 2025

The use of SGLT-2 inhibitors does not appear to pose an elevated risk of urinary tract infection (UTI) among male veterans with type 2 diabetes (T2D), a recent study has shown.

SGLT-2 inhibitors show no risk increase in UTI among veterans

28 Jul 2025

COVID-19 ups risk of hospitalization, treatment disruptions, death among cancer patients

26 Jul 2025

COVID-19 appears to have adverse consequences for patients with cancer, including increased hospitalization, treatment disruption, and death, according to a study.

COVID-19 ups risk of hospitalization, treatment disruptions, death among cancer patients

26 Jul 2025

Real-world use affirms RSVpreF efficacy at preventing LRTD in infants

26 Jul 2025

Maternal immunization with the bivalent respiratory syncytial virus (RSV) prefusion F vaccine (RSVpreF) helps lower the incidence of RSV-related lower respiratory tract disease (LRTD) and severe LRTD leading to hospitalization among infants from birth through age 6 months, according to real-world data from the BERNI study.

Real-world use affirms RSVpreF efficacy at preventing LRTD in infants

26 Jul 2025

Olorofim shows promise in invasive fungal disease

23 Jul 2025

In patients with invasive fungal disease (IFD) who have few or no treatment options, olorofim demonstrates efficacy and good tolerability, according to the results of a single-arm, open-label phase IIb study.

Olorofim shows promise in invasive fungal disease

23 Jul 2025

COVID-19 booster shots confer protection against severe disease in cancer patients

23 Jul 2025 by

Patients with cancer who have received COVID-19 booster vaccinations are better protected against severe disease, according to real-world data from four healthcare systems in the US.

COVID-19 booster shots confer protection against severe disease in cancer patients

23 Jul 2025

Nirsevimab efficacy against RSV-LRTI hospitalization sustained at 6 months

23 Jul 2025 by

Updated results from the phase IIIB HARMONIE trial demonstrate sustained efficacy of the long-acting monoclonal antibody nirsevimab against respiratory syncytial virus-associated lower respiratory tract infection (RSV-LRTI) hospitalization through day 181 post-dose.

Nirsevimab efficacy against RSV-LRTI hospitalization sustained at 6 months

23 Jul 2025

Early-onset neonatal sepsis ups risk of childhood epilepsy

23 Jul 2025

Infants who contract an invasive bacterial infection during the first week of life have double the risk of epilepsy in childhood, according to a register-based cohort study from Denmark.

Early-onset neonatal sepsis ups risk of childhood epilepsy

23 Jul 2025

Exercise-based rehab improves exercise capacity in long COVID patients

21 Jul 2025 by

Results from the PHOSP-R* trial show that exercise-based rehabilitation (EBR) improves short-term exercise capacity in individuals with post-COVID syndrome (long COVID) following an acute hospitalization.

Exercise-based rehab improves exercise capacity in long COVID patients

21 Jul 2025

Pandemic fuels burden of non-COVID diseases

19 Jul 2025 by

Disease burden has significantly increased because of the COVID-19 pandemic, particularly mental health disorders, malaria in young children in the African region, and stroke and ischaemic heart disease in older adults, reports a study.

Pandemic fuels burden of non-COVID diseases

19 Jul 2025

Infection-related deaths not uncommon among cancer survivors

18 Jul 2025

Many patients living with cancer die of infection, and early identification of those at risk is important to prevent infection-related mortality, according to a study.

Infection-related deaths not uncommon among cancer survivors

18 Jul 2025

News & Updates

Filter by Specialty:

Specialty:

SGLT-2 inhibitors show no risk increase in UTI among veterans

SGLT-2 inhibitors show no risk increase in UTI among veterans

COVID-19 ups risk of hospitalization, treatment disruptions, death among cancer patients

COVID-19 ups risk of hospitalization, treatment disruptions, death among cancer patients

Real-world use affirms RSVpreF efficacy at preventing LRTD in infants

Real-world use affirms RSVpreF efficacy at preventing LRTD in infants

Olorofim shows promise in invasive fungal disease

Olorofim shows promise in invasive fungal disease

COVID-19 booster shots confer protection against severe disease in cancer patients

COVID-19 booster shots confer protection against severe disease in cancer patients

Nirsevimab efficacy against RSV-LRTI hospitalization sustained at 6 months

Nirsevimab efficacy against RSV-LRTI hospitalization sustained at 6 months

Early-onset neonatal sepsis ups risk of childhood epilepsy

Early-onset neonatal sepsis ups risk of childhood epilepsy

Exercise-based rehab improves exercise capacity in long COVID patients

Exercise-based rehab improves exercise capacity in long COVID patients

Pandemic fuels burden of non-COVID diseases

Pandemic fuels burden of non-COVID diseases

Infection-related deaths not uncommon among cancer survivors

Infection-related deaths not uncommon among cancer survivors